Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 4/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 6/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CHUK | O15111 | 1/20 | 0.32 |
| ▸ | MAP3K8 | P41279 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758561 | 0.95 | CYP11B2 (0.43) | CYP11B2CYP11B1SLC22A12ABL1CYP17A1 | |
| SCHEMBL21758703 | 0.91 | CYP11B2 (0.48) | CYP11B2CYP11B1SLC22A12ABL1CYP17A1 | |
| SCHEMBL21758706 | 0.91 | CYP11B2 (0.42) | CYP11B2CYP11B1SLC22A12ABL1CYP17A1 | |
| SCHEMBL21758179 | 0.88 | CYP11B2 (0.45) | CYP11B2CYP11B1SLC22A12ABL1CYP17A1 | |
| SCHEMBL21758691 | 0.88 | CYP11B2 (0.41) | CYP11B2CYP11B1SLC22A12CYP17A1FLT3 | |
| SCHEMBL21758156 | 0.87 | CYP11B2 (0.41) | CYP11B2CYP11B1SLC22A12KDM1ACHUK | |
| SCHEMBL21758489 | 0.87 | CYP11B2 (0.41) | CYP11B2CYP11B1SLC22A12CYP17A1FLT3 | |
| SCHEMBL21758484 | 0.85 | CHUK (0.42) | CYP11B2CYP11B1SLC22A12CYP17A1FLT3 | |
| SCHEMBL21758498 | 0.85 | CYP11B2 (0.49) | CYP11B2CYP11B1SLC22A12ABL1CYP17A1 | |
| SCHEMBL21758160 | 0.85 | CYP11B2 (0.39) | CYP11B2CYP11B1SLC22A12CYP17A1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | CYP11B2 1243/4885CYP11B1 1224/4885SLC22A12 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.